标普和纳斯达克内在价值 联系我们

Fonar Corporation PFD A NV NEW FONRP

• Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
65/100
3/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Fonar Corporation PFD A NV NEW (FONRP) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 61/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
100/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
0/100
→ Income
~
成长
55/100
→ Income
收入
70/100
→ Income

估值概览 — FONRP

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$2.36
每股账面价值$0.00
每股营收$13.45
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2012 $1,134.35 $39.44B $6.88B 17.4%
2013 $1.43 $49.14M $8.68M 17.7%
2014 $1.69 $68.51M $10.4M 15.2%
2015 $2.09 $69.05M $12.91M 18.7%
2016 $2.55 $73.37M $15.72M 21.4%
2017 $3.12 $78.04M $19.62M 25.1%
2018 $3.31 $81.52M $21.23M 26%
2019 $2.36 $87.19M $15.32M 17.6%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言